MRK — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Merck & Co., Inc.
Healthcare · $120.87
1.0
/10
Avoid
How this score works →
Regime
Bullish
vs SMA200
SMA200 Distance
+25.4%
Above trend
Volatility
Low
Thin premiums
Momentum
Positive
Price direction
About Merck & Co., Inc.
Merck is a global pharma giant anchored by Keytruda, its blockbuster oncology franchise. Pays a reliable dividend, low beta (~0.4), defensive. Patent cliff concerns create periodic IV spikes, but overall volatility is low. A textbook defensive CSP name — modest premiums but high probability of success.
Drug Manufacturers - General
Market Cap
$298.8B
P/E Ratio
16.6
Dividend
281.00%
Beta
0.28
52-Week Range Current: $120.87
$73.31 $125.14
Earnings
2026-04-30
25 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE